Annual Working Capital
$20.48 M
-$20.54 M-50.07%
31 December 2023
Summary:
Lineage Cell Therapeutics annual working capital is currently $20.48 million, with the most recent change of -$20.54 million (-50.07%) on 31 December 2023. During the last 3 years, it has fallen by -$15.75 million (-43.47%). LCTX annual working capital is now -68.21% below its all-time high of $64.43 million, reached on 31 December 2021.LCTX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$20.54 M
-$4.58 M-18.23%
30 September 2024
Summary:
Lineage Cell Therapeutics quarterly working capital is currently $20.54 million, with the most recent change of -$4.58 million (-18.23%) on 30 September 2024. Over the past year, it has dropped by -$7.06 million (-25.59%). LCTX quarterly working capital is now -68.31% below its all-time high of $64.81 million, reached on 30 June 2021.LCTX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LCTX Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -50.1% | -25.6% |
| 3 y3 years | -43.5% | -65.5% |
| 5 y5 years | -30.7% | -62.9% |
LCTX Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -68.2% | at low | -68.1% | +0.3% |
| 5 y | 5 years | -68.2% | at low | -68.3% | +0.3% |
| alltime | all time | -68.2% | +726.4% | -68.3% | +630.6% |
Lineage Cell Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $20.54 M(-18.2%) |
| June 2024 | - | $25.11 M(-12.9%) |
| Mar 2024 | - | $28.83 M(+40.7%) |
| Dec 2023 | $20.48 M(-50.1%) | $20.48 M(-25.8%) |
| Sept 2023 | - | $27.60 M(-14.9%) |
| June 2023 | - | $32.44 M(+0.0%) |
| Mar 2023 | - | $32.43 M(-20.9%) |
| Dec 2022 | $41.02 M(-36.3%) | $41.02 M(-10.4%) |
| Sept 2022 | - | $45.77 M(-6.5%) |
| June 2022 | - | $48.94 M(-14.6%) |
| Mar 2022 | - | $57.28 M(-11.1%) |
| Dec 2021 | $64.43 M(+77.8%) | $64.43 M(+8.2%) |
| Sept 2021 | - | $59.55 M(-8.1%) |
| June 2021 | - | $64.81 M(+11.7%) |
| Mar 2021 | - | $58.00 M(+60.1%) |
| Dec 2020 | $36.23 M(-29.0%) | $36.23 M(+13.3%) |
| Sept 2020 | - | $31.98 M(-17.3%) |
| June 2020 | - | $38.68 M(-14.6%) |
| Mar 2020 | - | $45.31 M(-11.2%) |
| Dec 2019 | $51.02 M(+72.7%) | $51.02 M(-7.9%) |
| Sept 2019 | - | $55.42 M(+339.9%) |
| June 2019 | - | $12.60 M(-42.6%) |
| Mar 2019 | - | $21.93 M(-25.8%) |
| Dec 2018 | $29.55 M(-17.3%) | $29.55 M(-8.8%) |
| Sept 2018 | - | $32.40 M(+13.1%) |
| June 2018 | - | $28.65 M(-5.5%) |
| Mar 2018 | - | $30.32 M(-15.2%) |
| Dec 2017 | $35.74 M(+112.8%) | $35.74 M(+107.7%) |
| Sept 2017 | - | $17.21 M(+43.5%) |
| June 2017 | - | $11.99 M(-41.3%) |
| Mar 2017 | - | $20.44 M(+21.7%) |
| Dec 2016 | $16.80 M(-51.7%) | $16.80 M(-37.3%) |
| Sept 2016 | - | $26.81 M(+13.4%) |
| June 2016 | - | $23.64 M(+22.9%) |
| Mar 2016 | - | $19.24 M(-44.7%) |
| Dec 2015 | $34.77 M(+37.3%) | $34.77 M(+44.7%) |
| Sept 2015 | - | $24.03 M(-13.6%) |
| June 2015 | - | $27.81 M(+36.7%) |
| Mar 2015 | - | $20.34 M(-19.7%) |
| Dec 2014 | $25.34 M(+2453.8%) | $25.34 M(+510.4%) |
| Sept 2014 | - | $4.15 M(-69.4%) |
| June 2014 | - | $13.58 M(+274.4%) |
| Mar 2014 | - | $3.63 M(+265.5%) |
| Dec 2013 | $992.10 K(-64.4%) | $992.10 K(-75.7%) |
| Sept 2013 | - | $4.08 M(-70.2%) |
| June 2013 | - | $13.70 M(+57.9%) |
| Mar 2013 | - | $8.67 M(+211.0%) |
| Dec 2012 | $2.79 M(-87.2%) | $2.79 M(-61.1%) |
| Sept 2012 | - | $7.18 M(-38.4%) |
| June 2012 | - | $11.64 M(-30.2%) |
| Mar 2012 | - | $16.68 M(-23.5%) |
| Dec 2011 | $21.81 M(-34.1%) | $21.81 M(-15.6%) |
| Sept 2011 | - | $25.83 M(-1.1%) |
| June 2011 | - | $26.13 M(-12.6%) |
| Mar 2011 | - | $29.89 M(-9.7%) |
| Dec 2010 | $33.09 M(+195.4%) | $33.09 M(+30.2%) |
| Sept 2010 | - | $25.41 M(+44.3%) |
| June 2010 | - | $17.60 M(+71.4%) |
| Mar 2010 | - | $10.27 M(-8.3%) |
| Dec 2009 | $11.20 M(-442.7%) | $11.20 M(+58.7%) |
| Sept 2009 | - | $7.06 M(+1343.6%) |
| June 2009 | - | $488.90 K(-112.8%) |
| Mar 2009 | - | -$3.83 M(+17.2%) |
| Dec 2008 | -$3.27 M | -$3.27 M(-15.5%) |
| Sept 2008 | - | -$3.87 M(+54.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2008 | - | -$2.51 M(+51.8%) |
| Mar 2008 | - | -$1.66 M(+25.8%) |
| Dec 2007 | -$1.32 M(<-9900.0%) | -$1.32 M(+37.3%) |
| Sept 2007 | - | -$958.50 K(+26.3%) |
| June 2007 | - | -$759.20 K(+50.5%) |
| Mar 2007 | - | -$504.30 K(<-9900.0%) |
| Dec 2006 | $3000.00(-99.8%) | $3000.00(-99.0%) |
| Sept 2006 | - | $315.20 K(-51.4%) |
| June 2006 | - | $649.20 K(-50.0%) |
| Mar 2006 | - | $1.30 M(+6.0%) |
| Dec 2005 | $1.23 M(+23.6%) | $1.23 M(+301.0%) |
| Sept 2005 | - | $305.50 K(-29.5%) |
| June 2005 | - | $433.60 K(-21.9%) |
| Mar 2005 | - | $555.40 K(-44.0%) |
| Dec 2004 | $991.50 K(-147.5%) | $991.50 K(-32.6%) |
| Sept 2004 | - | $1.47 M(-25.4%) |
| June 2004 | - | $1.97 M(-3.6%) |
| Mar 2004 | - | $2.04 M(-197.9%) |
| Dec 2003 | -$2.09 M(-336.2%) | -$2.09 M(+40.6%) |
| Sept 2003 | - | -$1.48 M(-468.4%) |
| June 2003 | - | $402.80 K(-54.9%) |
| Mar 2003 | - | $892.20 K(+1.0%) |
| Dec 2002 | $883.70 K(-39.2%) | $883.70 K(-43.2%) |
| Sept 2002 | - | $1.56 M(+579.7%) |
| June 2002 | - | $228.80 K(-75.0%) |
| Mar 2002 | - | $915.50 K(-37.0%) |
| Dec 2001 | $1.45 M(+34.4%) | $1.45 M(-215.0%) |
| Sept 2001 | - | -$1.26 M(+236.3%) |
| June 2001 | - | -$375.70 K(-170.2%) |
| Mar 2001 | - | $535.50 K(-50.5%) |
| Dec 2000 | $1.08 M(-77.5%) | $1.08 M(-44.4%) |
| Sept 2000 | - | $1.94 M(-12.8%) |
| June 2000 | - | $2.23 M(-39.0%) |
| Mar 2000 | - | $3.66 M(-23.9%) |
| Dec 1999 | $4.80 M(+118.4%) | $4.80 M(-22.5%) |
| Sept 1999 | - | $6.20 M(-20.5%) |
| June 1999 | - | $7.80 M(-11.4%) |
| Mar 1999 | - | $8.80 M(+183.9%) |
| Dec 1998 | $2.20 M(-40.5%) | - |
| Sept 1998 | - | $3.10 M(-16.2%) |
| June 1998 | - | $3.70 M(-19.6%) |
| June 1998 | $3.70 M(-46.4%) | - |
| Mar 1998 | - | $4.60 M(-20.7%) |
| Dec 1997 | - | $5.80 M(-7.9%) |
| Sept 1997 | - | $6.30 M(-8.7%) |
| June 1997 | $6.90 M(+146.4%) | $6.90 M(-8.0%) |
| Mar 1997 | - | $7.50 M(+294.7%) |
| Dec 1996 | - | $1.90 M(-13.6%) |
| Sept 1996 | - | $2.20 M(-21.4%) |
| June 1996 | $2.80 M(-12.5%) | $2.80 M(0.0%) |
| Sept 1995 | - | $2.80 M(-12.5%) |
| June 1995 | $3.20 M(-44.8%) | $3.20 M(-17.9%) |
| Mar 1995 | - | $3.90 M(-11.4%) |
| Dec 1994 | - | $4.40 M(-17.0%) |
| Sept 1994 | - | $5.30 M(-8.6%) |
| June 1994 | $5.80 M(+65.7%) | $5.80 M(-7.9%) |
| Mar 1994 | - | $6.30 M(+142.3%) |
| Dec 1993 | - | $2.60 M(-25.7%) |
| Sept 1993 | - | $3.50 M(0.0%) |
| June 1993 | $3.50 M(-23.9%) | $3.50 M(-7.9%) |
| Mar 1993 | - | $3.80 M(-5.0%) |
| Dec 1992 | - | $4.00 M(-7.0%) |
| Sept 1992 | - | $4.30 M(-6.5%) |
| June 1992 | $4.60 M | $4.60 M(-8.0%) |
| Mar 1992 | - | $5.00 M |
FAQ
- What is Lineage Cell Therapeutics annual working capital?
- What is the all time high annual working capital for Lineage Cell Therapeutics?
- What is Lineage Cell Therapeutics annual working capital year-on-year change?
- What is Lineage Cell Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Lineage Cell Therapeutics?
- What is Lineage Cell Therapeutics quarterly working capital year-on-year change?
What is Lineage Cell Therapeutics annual working capital?
The current annual working capital of LCTX is $20.48 M
What is the all time high annual working capital for Lineage Cell Therapeutics?
Lineage Cell Therapeutics all-time high annual working capital is $64.43 M
What is Lineage Cell Therapeutics annual working capital year-on-year change?
Over the past year, LCTX annual working capital has changed by -$20.54 M (-50.07%)
What is Lineage Cell Therapeutics quarterly working capital?
The current quarterly working capital of LCTX is $20.54 M
What is the all time high quarterly working capital for Lineage Cell Therapeutics?
Lineage Cell Therapeutics all-time high quarterly working capital is $64.81 M
What is Lineage Cell Therapeutics quarterly working capital year-on-year change?
Over the past year, LCTX quarterly working capital has changed by -$7.06 M (-25.59%)